Literature DB >> 2864708

Drug interactions with cimetidine: an update.

M C Gerber, G A Tejwani, N Gerber, J R Bianchine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864708     DOI: 10.1016/0163-7258(85)90075-0

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  17 in total

1.  Influence of the H2-receptor antagonists cimetidine and ranitidine on the pharmacokinetics of nimodipine in healthy volunteers.

Authors:  W Mück; W Wingender; M Seiberling; E Woelke; K D Rämsch; J Kuhlmann
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 2.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

Review 4.  Drug interactions that matter. A critical reappraisal.

Authors:  G T McInnes; M J Brodie
Journal:  Drugs       Date:  1988-07       Impact factor: 9.546

5.  The influence of cimetidine versus ranitidine on doxepin pharmacokinetics.

Authors:  D L Sutherland; A J Remillard; K R Haight; M A Brown; L Old
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.

Authors:  P N Shaw; J B Houston
Journal:  J Pharmacokinet Biopharm       Date:  1987-10

7.  Do nizatidine and cimetidine interact with ibuprofen?

Authors:  D R Forsyth; K S Jayasinghe; C J Roberts
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

8.  Interaction of oxaprozin with acetaminophen, cimetidine, and ranitidine.

Authors:  J M Scavone; D J Greenblatt; R Matlis; J S Harmatz
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  Moclobemide treatment causes a substantial rise in the sparteine metabolic ratio. Danish University Antidepressant Group.

Authors:  L F Gram; K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1993-06       Impact factor: 4.335

Review 10.  Clinical pharmacokinetics of famotidine.

Authors:  H Echizen; T Ishizaki
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.